Advanced Health Intelligence (AHI) is a pioneer in digital healthcare solutions, transforming the way health information is captured, assessed, and utilized. Leveraging proprietary technology and artificial intelligence, AHI delivers smartphone-based health risk assessments that provide quick, convenient, and actionable insights into cardiovascular, metabolic, and mental health risks. Their core products—including Digital Health Assessment, FaceScan, and BodyScan—empower individuals and organizations to self-assess vital signs, body composition, and disease risks in minutes via web or mobile devices.
AHI’s solutions are designed to address key challenges in modern healthcare such as early identification of chronic conditions, effective population risk stratification, and extending prevention and care support to remote or underserved populations. Their technology enables contactless, non-invasive health screening that can be self-administered securely from anywhere, streamlining processes for healthcare providers, insurers, and governments alike. This approach not only facilitates greater access to prevention and early intervention but also supports data-driven, personalized health coaching and education.
With a foundation in rigorous, peer-reviewed science and a strong portfolio of global patents, AHI’s digital biomarker solutions are validated against clinical standards and are trusted by leading health institutions worldwide. The company is committed to user data security through end-to-end encryption and user-driven privacy controls. By delivering health intelligence at scale, Advanced Health Intelligence aims to create a more efficient, accessible, and equitable healthcare ecosystem for individuals and whole populations around the world.
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X does not hold an Australian Financial Services Licence (AFSL) and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any financial product advice provided.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
